SOP for source data verification NZ – Clinical Research Made Simple

SOP for Clinical Trial Data Management and Integrity

digi — Tue, 09 Sep 2025 21:02:39 +0000

SOP for Clinical Trial Data Management and Integrity

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/clinical-trial-data-management-and-integrity”
},
“@id”: “https://www.clinicalstudies.in/clinical-trial-data-management-and-integrity”,
“headline”: “SOP for Clinical Trial Data Management and Integrity”,
“name”: “SOP for Clinical Trial Data Management and Integrity”,
“description”: “Detailed SOP describing sponsor, investigator, and CRO responsibilities for clinical trial data management and integrity in New Zealand, ensuring compliance with Medsafe, HDEC, and ICH GCP requirements.”,
“keywords”: “Data management SOP NZ, SOP for clinical trial data management NZ, SOP for EDC compliance NZ, SOP for CRF handling NZ, SOP for database lock NZ, SOP for query management NZ, SOP for source data verification NZ, SOP for PI data responsibilities NZ, SOP for sponsor data oversight NZ, SOP for CRO data management NZ, SOP for HDEC data requirements NZ, SOP for Medsafe data compliance, SOP for trial data integrity NZ, SOP for GCP compliance data management NZ, SOP for inspection readiness data NZ, SOP for data cleaning NZ, SOP for database validation NZ, SOP for data privacy NZ, SOP for archiving trial data NZ, SOP for audit trail compliance NZ, SOP for electronic records NZ, SOP for data confidentiality NZ, SOP for trial subject protection data NZ, SOP for CAPA in data findings NZ, SOP for quality assurance data NZ”,
“articleSection”: “Standard Operating Procedure”,
“datePublished”: “2025-08-28”,
“dateModified”: “2025-08-28”,
“author”: { “@type”: “Organization”, “name”: “Clinicalstudies.in” },
“publisher”: {
“@type”: “Organization”,
“name”: “Clinicalstudies.in”,
“logo”: { “@type”: “ImageObject”, “url”: “https://www.clinicalstudies.in/logo.png” }
}
}

Clinical Trial Data Management and Integrity SOP

Department	Clinical Research
SOP No.	CS/NZ-DM/210/2025
Supersedes	N.A.
Page No.	1 of 26
Issue Date	28/08/2025
Effective Date	05/09/2025
Review Date	05/09/2027

Purpose

The purpose of this SOP is to define standardized processes for managing and safeguarding clinical trial data in New Zealand. It ensures integrity, accuracy, and confidentiality of data in compliance with Medsafe, HDEC, and ICH GCP requirements.

Scope

This SOP applies to all sponsor-led and investigator-initiated trials in New Zealand. It covers Case Report Form (CRF) handling, data entry, query resolution, database validation, database lock, audit trails, and archiving. It applies to sponsors, investigators, CROs, data managers, and QA teams.

Responsibilities

Sponsor: Establishes data management plan, ensures secure EDC systems, and oversees CRO activities.
Principal Investigator (PI): Ensures accuracy of site-level data entry and resolution of queries.
Clinical Research Coordinator (CRC): Assists in timely data entry and source verification.
Data Manager: Oversees data validation, query generation, and database lock.
CRO: Provides data management services when delegated by sponsor.
Quality Assurance (QA): Audits data management processes and ensures CAPA implementation.

Accountability

The sponsor’s Head of Data Management is accountable for data management compliance. The PI is accountable for site-level data accuracy and completeness.

Procedure

1. Data Management Plan (DMP)

Prepare and approve a DMP covering CRF handling, query management, database validation, and archiving.
Maintain DMP in Trial Master File (TMF).

2. CRF Handling and Data Entry

Ensure CRFs are completed promptly and accurately.
Electronic CRFs (eCRFs) must be entered into EDC within 5 working days of subject visit.
Maintain CRF Completion Log (Annexure-1).

3. Query Management

Data managers issue queries for discrepancies.
Investigators resolve queries within 10 working days.
Maintain Query Resolution Log (Annexure-2).

4. Database Validation and Lock

Perform system validation checks prior to database lock.
Document lock approval in Database Lock Log (Annexure-3).

5. Data Privacy and Security

Ensure compliance with Privacy Act 2020.
De-identify subject data before analysis.
Maintain access control for EDC systems.

6. Archiving

Archive data management documentation in TMF and ISF for at least 10 years post-trial.
Ensure audit trails remain accessible for regulatory inspections.

Abbreviations

CRF: Case Report Form
eCRF: Electronic Case Report Form
PI: Principal Investigator
CRC: Clinical Research Coordinator
QA: Quality Assurance
CRO: Contract Research Organization
DMP: Data Management Plan
TMF: Trial Master File
ISF: Investigator Site File
CAPA: Corrective and Preventive Action
EDC: Electronic Data Capture
GCP: Good Clinical Practice
HDEC: Health and Disability Ethics Committees

Documents

CRF Completion Log (Annexure-1)
Query Resolution Log (Annexure-2)
Database Lock Log (Annexure-3)

References

Version: 1.0

Approval

Prepared By	Checked By	Approved By
Name: Rajesh Kumar Date: 20/08/2025 Signature: __________	Name: Sunita Reddy Date: 22/08/2025 Signature: __________	Name: Dr. Meera Iyer Date: 28/08/2025 Signature: __________

Annexures

Annexure-1: CRF Completion Log

Date	Subject ID	Visit	Completed By	Checked By
10/08/2025	NZ-801	Visit 1	CRC: Anjali Rao	PI: Dr. Anita Patel

Annexure-2: Query Resolution Log

Date	Query ID	Query Description	Resolution	Resolved By
15/08/2025	QRY-2101	Missing AE date	Date corrected	Dr. Anita Patel

Annexure-3: Database Lock Log

Date	Database Name	Status	Approved By
25/08/2025	NZ-2025-DB	Locked	Head of Data Management

Revision History

Revision Date	Revision No.	Revision Details	Reason for Revision	Approved By
28/08/2025	1.0	Initial SOP for clinical trial data management and integrity in New Zealand.	New SOP created for Medsafe, HDEC, Privacy Act 2020, and GCP compliance.	Head of Clinical Research

For more SOPs visit: Pharma SOP.

SOP for Clinical Trial Monitoring and Oversight

digi — Mon, 08 Sep 2025 09:42:14 +0000

SOP for Clinical Trial Monitoring and Oversight

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/clinical-trial-monitoring-and-oversight”
},
“@id”: “https://www.clinicalstudies.in/clinical-trial-monitoring-and-oversight”,
“headline”: “SOP for Clinical Trial Monitoring and Oversight”,
“name”: “SOP for Clinical Trial Monitoring and Oversight”,
“description”: “Comprehensive SOP describing sponsor, investigator, and monitor responsibilities for clinical trial monitoring and oversight in New Zealand, aligned with Medsafe, HDEC, and ICH GCP guidelines.”,
“keywords”: “Clinical monitoring SOP NZ, SOP for monitoring visits NZ, SOP for source data verification NZ, SOP for monitoring plan NZ, SOP for CRA responsibilities NZ, SOP for site monitoring NZ, SOP for Medsafe monitoring compliance, SOP for HDEC monitoring oversight, SOP for trial monitoring reports NZ, SOP for investigator monitoring responsibilities NZ, SOP for sponsor monitoring obligations NZ, SOP for CRO monitoring support NZ, SOP for remote monitoring NZ, SOP for on-site monitoring NZ, SOP for data integrity monitoring NZ, SOP for safety reporting monitoring NZ, SOP for protocol compliance monitoring NZ, SOP for monitoring visit documentation NZ, SOP for inspection readiness monitoring NZ, SOP for monitoring frequency NZ, SOP for corrective action monitoring NZ, SOP for GCP compliance monitoring NZ, SOP for monitoring training NZ, SOP for monitoring report archiving NZ, SOP for trial oversight monitoring NZ”,
“articleSection”: “Standard Operating Procedure”,
“datePublished”: “2025-08-28”,
“dateModified”: “2025-08-28”,
“author”: { “@type”: “Organization”, “name”: “Clinicalstudies.in” },
“publisher”: {
“@type”: “Organization”,
“name”: “Clinicalstudies.in”,
“logo”: { “@type”: “ImageObject”, “url”: “https://www.clinicalstudies.in/logo.png” }
}
}

Clinical Trial Monitoring and Oversight SOP

Department	Clinical Research
SOP No.	CS/NZ-MON/207/2025
Supersedes	N.A.
Page No.	1 of 27
Issue Date	28/08/2025
Effective Date	05/09/2025
Review Date	05/09/2027

Purpose

This SOP defines standardized processes for clinical trial monitoring and oversight in New Zealand. It ensures compliance with Medsafe, HDEC, and ICH GCP requirements to safeguard participant rights, ensure data integrity, and verify protocol adherence.

Scope

This SOP applies to all sponsor-led and investigator-initiated trials requiring monitoring in New Zealand. It covers planning, conducting, documenting, and archiving monitoring activities. It applies to sponsors, Clinical Research Associates (CRAs), investigators, CROs, and QA teams.

Responsibilities

Sponsor: Develops monitoring plan, ensures monitors are trained, and oversees CRO activities.
Principal Investigator (PI): Ensures site readiness, provides access to source data, and implements corrective actions.
CRA/Monitor: Conducts monitoring visits, verifies source data, and prepares monitoring reports.
Regulatory Affairs (RA): Provides oversight of monitoring compliance with Medsafe and HDEC expectations.
QA: Audits monitoring records and verifies implementation of CAPA.
CRO: Performs monitoring activities on behalf of sponsor if delegated.

Accountability

The sponsor’s Head of Clinical Operations is accountable for trial monitoring compliance. The PI is accountable for ensuring timely resolution of monitoring findings at site level.

Procedure

1. Monitoring Plan Development

Sponsor or CRO develops a risk-based monitoring plan.
Include monitoring frequency, visit types (remote/on-site), and SDV requirements.
File approved monitoring plan in TMF (Annexure-1).

2. Pre-Study Visit (PSV)

Evaluate site facilities, staff, and regulatory compliance readiness.
Document findings in PSV Report (Annexure-2).

3. Initiation Visit (SIV)

Train site staff on protocol, GCP, and reporting requirements.
Ensure essential documents are present in ISF.

4. Routine Monitoring Visits

Verify informed consent documentation.
Review source data for accuracy against CRFs/EDC entries.
Check investigational product accountability.
Document visit findings in Monitoring Visit Report (Annexure-3).

5. Close-Out Visit

Verify data completeness, archiving, and ISF reconciliation.
Ensure pending queries and CAPAs are resolved.

6. Documentation and Archiving

Maintain monitoring logs and reports in TMF and ISF.
Archive monitoring documentation for at least 10 years post-trial.